Table 1.
Target gene | Sequence of primers (5′-3′) c | Relative gene expression | |
---|---|---|---|
12.5 μg/ml | 6.25 μg/ml | ||
puvA | F, CAAACTCACTCAGACTC R, CGAACCGATTCAACAC |
1 | 1 |
tolc | F, CGCAACTCGTCGCCTAT R, TGTCTTGTTCGCTTAGTGTACCA |
−3.05 ± 0.41 ** | −1.12 ± 0.32 ** |
fla | F, AGATCGGTTTTGGTGATGC R, CGTTGGCTGTCTACTGATTTAAG |
−1.85 ± 0.19 ** | −1.17 ± 0.03 ** |
atpA | F, CGATGATCTATCTAAACAAGCGG R, TAAGTAGAATACGTCACCTGGGA |
−1.46 ± 0.43 ** | −1.26 ± 0.04 ** |
nusA | F, TGTTTATCACTCGTTCTAAGCCT R, GTTTGTCATTTGTTTTCACTGCG |
−2.18 ± 0.28 ** | −1.45 ± 0.12 ** |
flaA | F, CGGACTAAACCGTATCGCTGAAA R, GGCTGCCCATAGAAAGCATTACA |
−9.27 ± 1.05 ** | −2.24 ± 0.14 * |
flgL | F, CGTCAGCGTCCACCACTT R, GCGGCTCTGACTTACTGCTA |
−1.35 ± 0.48 ** | −1.27 ± 0.37 ** |
flgM | F, CGTCAGCGTCCACCACTT R, GCGGCTCTGACTTACTGCTA |
−1.57 ± 0.48 ** | −1.52 ± 0.03 ** |
dld | F, TTATCCCGCATGAAGACCC R, CCGATGATACCACCGCC |
−2.06 ± 0.07 ** | −1.35 ± 0.04 ** |
luxS | F, GGATTTTGTTCTGGCTTTCCACTT R, GGGATGTCGCACTGGTTTTTAC |
−9.17 ± 2.01 ** | −6.46 ± 1.41 ** |
ompW | F, TCGTGTCACCAAGTGTTTTCG R, CGTGGCTGAATGGTGTTGC |
−5.51 ± 0.49 ** | −1.38 ± 0.12 ** |
vopQ | F, CCACAAGTTTGCTTCGGTTAG R, GGTTCTCCTCGGTAGCCTGA |
−2.53 ± 0.22 ** | −2.34 ± 0.05 ** |
vp0950 | F, GCCAAACTTCTCAAACAACA R, ATGAAACGCAATTTACCATC |
−10.64 ± 0.63 ** | −3.50 ± 0.31 ** |
vp0952 | F, TATGATGGTGTTTGGTGC R, TGTTTTTCTGAGCGTTTC |
−2.43 ± 0.18 ** | −1.49 ± 0.06 ** |
vp0962 | F, GACCAAGACCCAGTGAGA R, GGTAAAGCCAGCAAAGTT |
−5.74 ± 0.84 ** | −1.46 ± 0.22 |
vpA0450 | F, TTGCTGAAGGCTCTGATG R, CTGCACTGGCTTATGGTC |
−2.79 ± 0.51 ** | −1.93 ± 0.19 ** |
aphA | F, ACACCCAACCGTTCGTGATG R, GTTGAAGGCGTTGCGTAGTAAG |
−1.21 ± 0.38 ** | −1.17 ± 0.02 ** |
toxR | F, ACAATGACGCCTCTGCTAAT R, ACTCACCAATCTGACGGAACT |
−2.87 ± 0.87 ** | −1.82 ± 0.15 ** |
p ≤ 0.05;
p ≤ 0.01;
F, forward; R, reverse.